Avid Bioservices to Participate in Morgan Stanley 20th Annual Global Healthcare Conference

Rhea-AI Summary

Avid Bioservices, a biologics contract development and manufacturing organization (CDMO), will participate in the Morgan Stanley 20^th Annual Global Healthcare Conference. The event is scheduled for September 12-14, 2022, in New York City. CEO Nick Green will lead a fireside chat on September 14 from 12:55 to 1:25 p.m. Eastern. The discussion will focus on the company's commitment to high-quality services in drug development and manufacturing. Interested parties can access the live webcast or the archived version via the company's investor relations website.

TUSTIN, Calif., Sept. 07, 2022 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, today announced that the company will participate in the Morgan Stanley 20^th Annual Global Healthcare Conference. Nick Green, president and chief executive officer of Avid Bioservices, will be the featured speaker in a fireside chat at the conference, which will take place September 12-14, 2022, in New York City.

Details of the company’s participation are as follows:

• Morgan Stanley 20^th Annual Global Healthcare Conference
  Conference Date: September 12-14, 2022
  Fireside Chat Time/Date: 12:55 - 1:25 p.m. Eastern on Wednesday, September 14, 2022
  Location: Sheraton New York Hotel; webcast available

To listen to the live webcast of the Morgan Stanley fireside chat, or access the archived webcast, please visit: http://ir.avidbio.com/investor-events.

About Avid Bioservices, Inc.  

Avid Bioservices (NASDAQ:CDMO), an S&P SmallCap 600 company, is a dedicated contract development and manufacturing organization (CDMO) focused on development and CGMP manufacturing of biologics. The company provides a comprehensive range of process development, CGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries. With 29 years of experience producing monoclonal antibodies and recombinant proteins, Avid's services include CGMP clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing and regulatory submissions support. For early-stage programs the company provides a variety of process development activities, including upstream and downstream development and optimization, analytical methods development, testing and characterization. The scope of our services ranges from standalone process development projects to full development and manufacturing programs through commercialization. www.avidbio.com

FAQ

What is the date of the Morgan Stanley 20th Annual Global Healthcare Conference for Avid Bioservices?

The Morgan Stanley 20th Annual Global Healthcare Conference will take place from September 12-14, 2022.

Who will represent Avid Bioservices at the conference?

Nick Green, president and CEO of Avid Bioservices, will speak in a fireside chat.

When is Avid Bioservices' fireside chat scheduled?

The fireside chat is scheduled for September 14, 2022, from 12:55 to 1:25 p.m. Eastern.

Where is the Morgan Stanley Healthcare Conference taking place?

The conference will be held at the Sheraton New York Hotel in New York City.

How can I access the webcast of Avid Bioservices' fireside chat?

You can listen to the live or archived webcast on Avid Bioservices' investor relations website.